These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34923222)
1. Balance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases. Harel M; Fauteux-Daniel S; Girard-Guyonvarc'h C; Gabay C Cytokine; 2022 Feb; 150():155781. PubMed ID: 34923222 [TBL] [Abstract][Full Text] [Related]
2. IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome. Baggio C; Bindoli S; Guidea I; Doria A; Oliviero F; Sfriso P Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446301 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-18: Biological properties and role in disease pathogenesis. Kaplanski G Immunol Rev; 2018 Jan; 281(1):138-153. PubMed ID: 29247988 [TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of free interleukin-18 in adult-onset Still's disease. Girard C; Rech J; Brown M; Allali D; Roux-Lombard P; Spertini F; Schiffrin EJ; Schett G; Manger B; Bas S; Del Val G; Gabay C Rheumatology (Oxford); 2016 Dec; 55(12):2237-2247. PubMed ID: 27616144 [TBL] [Abstract][Full Text] [Related]
5. The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still's Disease and Systemic Juvenile Idiopathic Arthritis. Girard-Guyonvarc'h C; Harel M; Gabay C J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054124 [TBL] [Abstract][Full Text] [Related]
6. The role of interleukin-18 and interleukin-18 binding protein in K/BxN serum transfer-induced arthritis. Fauteux-Daniel S; Merlo Pich LM; Girard-Guyonvarc'h C; Caruso A; Rodriguez E; Gabay C Front Immunol; 2023; 14():1215364. PubMed ID: 37415987 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults. Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I Front Immunol; 2021; 12():750114. PubMed ID: 34691064 [TBL] [Abstract][Full Text] [Related]
9. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Kawashima M; Yamamura M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Miyawaki S; Amano T; Takeuchi T; Makino H Arthritis Rheum; 2001 Mar; 44(3):550-60. PubMed ID: 11263769 [TBL] [Abstract][Full Text] [Related]
10. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis. Inoue N; Shimizu M; Tsunoda S; Kawano M; Matsumura M; Yachie A Clin Immunol; 2016 Aug; 169():8-13. PubMed ID: 27263804 [TBL] [Abstract][Full Text] [Related]
11. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease. Gabay C; Fautrel B; Rech J; Spertini F; Feist E; Kötter I; Hachulla E; Morel J; Schaeverbeke T; Hamidou MA; Martin T; Hellmich B; Lamprecht P; Schulze-Koops H; Courvoisier DS; Sleight A; Schiffrin EJ Ann Rheum Dis; 2018 Jun; 77(6):840-847. PubMed ID: 29472362 [TBL] [Abstract][Full Text] [Related]
13. Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases. Shimizu M; Takei S; Mori M; Yachie A Front Immunol; 2022; 13():951535. PubMed ID: 36211331 [TBL] [Abstract][Full Text] [Related]
14. Understanding of cytokines and targeted therapy in macrophage activation syndrome. Tang S; Li S; Zheng S; Ding Y; Zhu D; Sun C; Hu Y; Qiao J; Fang H Semin Arthritis Rheum; 2021 Feb; 51(1):198-210. PubMed ID: 33385860 [TBL] [Abstract][Full Text] [Related]
15. Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease. Segú-Vergés C; Coma M; Kessel C; Smeets S; Foell D; Aldea A Arthritis Res Ther; 2021 Apr; 23(1):126. PubMed ID: 33892792 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 inhibition: a therapeutic strategy for the management of adult-onset Still's disease. Kaneko Y; Takeuchi T Expert Opin Biol Ther; 2022 Jan; 22(1):79-85. PubMed ID: 34126828 [TBL] [Abstract][Full Text] [Related]
17. Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease. Chen PK; Lan JL; Li JP; Chang CK; Chang SH; Huang PH; Yeo KJ; Chen DY Clin Rheumatol; 2020 Jun; 39(6):1945-1952. PubMed ID: 31960208 [TBL] [Abstract][Full Text] [Related]
18. [Current concepts on the physiopathology of adult-onset Still's disease]. Arlet JB; Le Thi Huong DB; Pouchot J; Piette JC Rev Med Interne; 2005 Jul; 26(7):549-56. PubMed ID: 15996569 [TBL] [Abstract][Full Text] [Related]
19. Immune-mediated inflammatory diseases with chronic excess of serum interleukin-18. Miyazawa H; Wada T Front Immunol; 2022; 13():930141. PubMed ID: 35958573 [No Abstract] [Full Text] [Related]
20. Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome. Harel M; Girard-Guyonvarc'h C; Rodriguez E; Palmer G; Gabay C J Immunol; 2020 Aug; 205(4):1167-1175. PubMed ID: 32651219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]